How has been the historical performance of Nexus Surgical?

Answer:The historical performance of Nexus Surgical shows a significant increase in net sales over the years, with Mar'25 reporting net sales of 5.72 Cr, up from 3.47 Cr in Mar'24 and 1.55 Cr in Mar'23. The total operating income has also risen consistently, reaching 5.72 Cr in Mar'25 compared to 3.47 Cr in Mar'24. The company's total expenditure, excluding depreciation, was 5.06 Cr in Mar'25, which is an increase from 3.21 Cr in Mar'24. This resulted in an operating profit of 0.67 Cr for Mar'25, up from 0.29 Cr in Mar'24. Profit before tax also increased to 0.67 Cr in Mar'25 from 0.29 Cr in Mar'24, leading to a profit after tax of 0.50 Cr in Mar'25, compared to 0.21 Cr in Mar'24. The earnings per share (EPS) improved to 0.91 in Mar'25 from 0.38 in Mar'24. On the balance sheet, total assets rose to 2.27 Cr in Mar'25 from 1.80 Cr in Mar'24, while total liabilities increased to 2.27 Cr in Mar'25 from 1.80 Cr in Mar'24. The book value per share adjusted also improved to 1.94 in Mar'25 from 1.03 in Mar'24.

Breakdown:
Nexus Surgical has demonstrated a strong upward trend in its financial performance over the years. The net sales surged to 5.72 Cr in Mar'25, reflecting a robust growth trajectory from previous years. This growth in revenue has translated into an operating profit of 0.67 Cr, marking a significant improvement from the prior year. The profit before tax mirrored this positive trend, reaching 0.67 Cr, while the profit after tax also saw a notable increase to 0.50 Cr. The company's earnings per share have improved substantially, indicating enhanced shareholder value. On the balance sheet, total assets and liabilities both increased to 2.27 Cr, suggesting a balanced growth in the company's financial structure. Overall, Nexus Surgical's financial metrics indicate a solid recovery and growth phase, showcasing its potential for future performance.